LUXEMBOURG | WP3 | |||
Organization | CON-VINCE | |||
Name of cohort | CON-VINCE | |||
Referring partner | LIH | |||
Cohort Information | Country(-ies), cities, regions or centers involved | Luxembourg | ||
Time of data collection | 04/2020 | 11/2024 | ||
Enrolment | Active | |||
Study setting | Single center | |||
Population | Age | Adults,Elderly | ||
Type | Both | |||
Total number of patients | 1800 | |||
Data collection | Clinical data | True | ||
Serological data | True | |||
Genetic data | False | |||
Sample collection | True | |||
Sample collected | Whole blood | Yes | ||
PBMC | No | |||
Dry-spot blood | Yes | |||
Plasma | Yes | |||
Serum | Yes | |||
Stool | Yes | |||
NP swabs | Yes | |||
Other | None | |||
Description | The main goal of this project is to understand the prevalence, dynamics, and penetrance of the infection within the Luxembourgish population. To achieve this, the three categories of asymptomatic or oligosymptomatic (presenting mild symptoms as defined in the inclusion criteria below) people indicated above will be identified and systematically analyzed using comprehensive clinical, epidemiological, psychological, and biological assessments. It would be possible to add additional questions to the CRF used in future timepoints, we have recently added these topics to our eCRF. | |||
Publications |
- Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern [International Journal of Molecular Sciences] |